Limited coverage drugs – gliclazide

Last updated on August 26, 2024

Special Authority requests can now be submitted online. It's simple and quick!

This drug is eligible for automatic approval when patient meets criteria and the request is submitted by eForms.

Generic name	gliclazide
Strength	30 mg, 60 mg modified release 80 mg
Form	tablet (regular or modified release)

Special Authority criteria	Approval period
For the treatment of type 2 diabetes, when the patient has demonstrated treatment failure or intolerance to at least one other sulfonylurea drug (e.g., glyburide, tolbutamide) at adequate doses.	Indefinite

Practitioner exemptions

No practitioner exemptions.

Special notes

Gliclazide is a regular benefit for Plan W (First Nations Health Benefits) recipients.

Special Authority request form(s)

Log in to eForms
HLTH 5328 - Special Authority Request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – gliclazide

Practitioner exemptions

Special notes

Special Authority request form(s)